Cvr Refining LP (CVRR) 6.68 $CVRR CVR Refining Reports

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2016 at 1:01 AM

Cvr Refining LP (CVRR) 6.68 $CVRR

CVR Refining Reports 2016 Second Quarter Results
PR Newswire - Thu Jul 28, 7:30AM CDT
CVR Refining, LP (NYSE: CVRR), a refiner and marketer of petroleum fuels, today announced second quarter 2016 net income of $78.1 million on net sales of $1,164.4 million, compared to net income of $227.8 million on net sales of $1,547.5 million for the second quarter of 2015. Adjusted EBITDA, a non-GAAP financial measure, for the 2016 second quarter was $84.7 million compared to adjusted EBITDA of $194.3 million for the 2015 second quarter.
CVRR: 6.68 (+0.01)

Zacks.com featured highlights: CVR Refining, Korea Electric Power, Owens-Illinois, BG Staffing and Banco Bilbao Vizcaya Argentaria
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 8:30AM CDT
Zacks.com featured highlights: CVR Refining, Korea Electric Power, Owens-Illinois, BG Staffing and Banco Bilbao Vizcaya Argentaria
KEP: 25.87 (+0.11), OI: 18.06 (+0.28), BGSF: 17.58 (+0.12), BBVA: 6.36 (+0.07), CVRR: 6.68 (+0.01)

Continental Resources Hits 52-Week High on Oil Recovery
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:42AM CDT
Shares of leading oil producer Continental Resources, Inc. (CLR) hit a 52-week high of $45.92 during Thursday's trading session.
SOL: 1.14 (-0.03), CLR: 50.29 (+1.54), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01)

5 Best Value Stocks Making the Most of P/B Ratio
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:02AM CDT
The P/B ratio is used to calculate how much an investor needs to pay for each dollar of book value of a stock.
KEP: 25.87 (+0.11), CUK: 46.91 (-2.59), SBS: 9.49 (+0.57), DF: 17.25 (+0.20), CVRR: 6.68 (+0.01)

5 High Earnings Yield Stocks to Buy Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 6:25AM CDT
Earnings Yield is a useful ratio for investors who play in both stocks and bonds.
KEP: 25.87 (+0.11), OI: 18.06 (+0.28), BGSF: 17.58 (+0.12), BBVA: 6.36 (+0.07), CVRR: 6.68 (+0.01)

Noble Corp Receives Full Settlement from Freeport-McMoRan
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 5:33AM CDT
Noble Corporation plc (NE) announced that it has received the full settlement value of $540 million from Freeport-McMoRan Inc. (FCX).
SOL: 1.14 (-0.03), FCX: 10.48 (+0.13), CVRR: 6.68 (+0.01), NE: 5.82 (+0.15)

Range Resources (RRC) Gets Approval to Spud Trinidad Well
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 5:32AM CDT
Range Resources Corp. (RRC) announced that it has received approval from the regulatory bodies in Trinidad to spud the MD 51-2 development well.
SOL: 1.14 (-0.03), FF: 11.70 (+0.12), RRC: 40.47 (+1.40), CVRR: 6.68 (+0.01)

Energen in Non-Core Assets' Purchase and Sale Agreements
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:28AM CDT
Energen Corp. (EGN) announced that it has signed purchase and sale agreements for its non-core Delaware Basin and San Juan Basin assets.
SOL: 1.14 (-0.03), EGN: 59.46 (+0.98), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01)

Enterprise (EPD) to Build Third Cryogenic Plant in Delaware
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:39AM CDT
Enterprise Products Partners L.P. (EPD) intends to build a new cryogenic natural gas processing facility and related natural gas and natural gas liquids (NGL) pipeline infrastructure.
SOL: 1.14 (-0.03), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01), EPD: 26.82 (+0.30)

BP on Track with the Atoll Phase One Project Development
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:35AM CDT
BP plc (BP), in association with the Egyptian Natural Gas Holding Company ("EGAS"

, has given consent for the development of the Atoll Phase One project.
SOL: 1.14 (-0.03), BP: 34.50 (+0.84), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01)

ExxonMobil's Russian Project May Get Nod to Export to China
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:31AM CDT
ExxonMobil Corp.???s (XOM) oil and gas project on the Russian Pacific island of Sakhalin is likely to get rights to export natural gas to China.
SOL: 1.14 (-0.03), XOM: 87.42 (+0.58), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01)

BP and Rosneft to Form Yermak Neftegaz LLC Joint Venture
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:28AM CDT
BP plc (BP) and Russian oil major Rosneft have inked a final binding agreement at the St Petersburg International Economic Forum ("SPIEF"

to form a new joint venture (JV) - Yermak Neftegaz LLC.
SOL: 1.14 (-0.03), BP: 34.50 (+0.84), FF: 11.70 (+0.12), CVRR: 6.68 (+0.01)

Noble Corp Fleet Status Report: Two Rig Contracts Terminated
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Noble Corporation (NE) announced that it has reached an agreement with its customer Freeport-McMoRan Oil & Gas LLC and its parent company, Freeport-McMoRan Inc. for the early termination of the drilling contracts for two of its drillships.
SOL: 1.14 (-0.03), SSL: 25.77 (+0.62), CVRR: 6.68 (+0.01), NE: 5.82 (+0.15)

Ferrellgas Partners (FGP) Closes Buyout of Selph's Propane
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 11:12PM CDT
Ferrellgas Partners LP (FGP) announced the acquisition of Colorado-based independent propane retailer, Selph's Propane.
WES: 50.56 (+0.57), FGP: 19.40 (-0.44), CVRR: 6.68 (+0.01), APC: 56.49 (+2.95)

Pioneer to Acquire Midland Basin Acreage, Add Rigs in 2Q16
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 9:46AM CDT
Pioneer Natural Resources Company (PXD) has entered into a purchase and sale agreement with Devon Energy Corporation (DVN) to acquire about 28,000 net acres in the Midland Basin.
SOL: 1.14 (-0.03), DVN: 44.27 (+0.57), PXD: 183.71 (+3.49), CVRR: 6.68 (+0.01)

CNOOC's Yang Hua Assumes Twin Roles of Chairman & CEO
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:44AM CDT
China National Offshore Oil Corp. (CEO), or CNOOC, recently announced that its Chairman Yang Hua has assumed the role of CEO also.
BAK: 15.08 (-0.01), CEO: 123.29 (+2.65), NADL: 3.41 (unch), CVRR: 6.68 (+0.01)

Falling Earnings Estimates Signal Weakness Ahead for Ferrellgas Partners (FGP)
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 7:51AM CDT
Ferrellgas Partners has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
FGP: 19.40 (-0.44), CVRR: 6.68 (+0.01)

Emerge Energy (EMES) in Focus: Stock Moves 9.3% Higher
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 7:30AM CDT
Emerge Energy Services LP (EMES) shares rose over 9% in the last trading session.
EMES: 11.78 (+0.36), CVRR: 6.68 (+0.01)

5 Value Stocks to Buy for Less Than $10/share
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 9:21AM CDT
Amid this uncertainty, it will be a prudent decision to stay invested in fundamentally sound companies that are unperturbed by market gyrations. It???s even better if such companies are undervalued.
KVHI: 8.77 (-0.11), PCOM: 8.46 (+0.25), MN: 7.59 (+0.10), MBT: 8.14 (+0.21), CVRR: 6.68 (+0.01)

Statoil's PDO of Oseberg Vestflanken 2 Approved by Authorities
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 9:02AM CDT
Statoil ASA's (STO) Plan for Development and Operation (PDO) of Oseberg Vestflanken 2 has received the permission from the Norwegian Ministry of Petroleum and Energy.
SOL: 1.14 (-0.03), PTR: 67.55 (+1.68), CVRR: 6.68 (+0.01), STO: 15.92 (+0.47)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...